Abbott Laboratories (ABT)
(Delayed Data from NYSE)
$104.09 USD
-0.78 (-0.74%)
Updated May 17, 2024 04:00 PM ET
After-Market: $104.01 -0.08 (-0.08%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth B Momentum C VGM
Brokerage Reports
Abbott Laboratories [ABT]
Reports for Purchase
Showing records 381 - 400 ( 524 total )
Company: Abbott Laboratories
Industry: Large Cap Pharmaceuticals
Niche stents and aggressive business initiatives - measures to drive overall performance
Provider: FIRST GLOBAL
Analyst: THOMAS K
Company: Abbott Laboratories
Industry: Large Cap Pharmaceuticals
Company: Abbott Laboratories
Industry: Large Cap Pharmaceuticals
Company: Abbott Laboratories
Industry: Large Cap Pharmaceuticals
Company: Abbott Laboratories
Industry: Large Cap Pharmaceuticals
Company: Abbott Laboratories
Industry: Large Cap Pharmaceuticals
Company: Abbott Laboratories
Industry: Large Cap Pharmaceuticals
Strengthening U.S. Dollar to be a major headwind in 2015, with 70% of total sales coming from outside the U.S
Provider: FIRST GLOBAL
Analyst: THOMAS K
Company: Abbott Laboratories
Industry: Large Cap Pharmaceuticals
Strengthening U.S. Dollar to be a major headwind in 2015, as 70% of ABTs sales comes from
Provider: FIRST GLOBAL
Analyst: THOMAS K
Company: Abbott Laboratories
Industry: Large Cap Pharmaceuticals
Company: Abbott Laboratories
Industry: Large Cap Pharmaceuticals
Company: Abbott Laboratories
Industry: Large Cap Pharmaceuticals
Company: Abbott Laboratories
Industry: Large Cap Pharmaceuticals
Company: Abbott Laboratories
Industry: Large Cap Pharmaceuticals
Company: Abbott Laboratories
Industry: Large Cap Pharmaceuticals
Company: Abbott Laboratories
Industry: Large Cap Pharmaceuticals
Company: Abbott Laboratories
Industry: Large Cap Pharmaceuticals
Strengthening U.S. Dollar to be a major headwind in 2015, as 70% of ABTs sales comes from
Provider: FIRST GLOBAL
Analyst: THOMAS K
Company: Abbott Laboratories
Industry: Large Cap Pharmaceuticals
Company: Abbott Laboratories
Industry: Large Cap Pharmaceuticals
Company: Abbott Laboratories
Industry: Large Cap Pharmaceuticals
Stable - improved growth prospects and increasing Emerging Markets mix augur well
Provider: FIRST GLOBAL
Analyst: THOMAS K
Company: Abbott Laboratories
Industry: Large Cap Pharmaceuticals
Management raises mid-point of CY14 EPS guidance range - expects strong double-digit EPS growth for CY14 and ahead...
Provider: FIRST GLOBAL
Analyst: THOMAS K